Nisa Leung is Managing Partner of Qiming Venture Partners, leading its health care investments. Qiming Venture Partners is a leading investment firm in China with over 480 portfolio companies.

She currently sits on the board of Zai Lab (NASDAQ:ZLAB; HKSE:9688), CanSino Biologics (SSE:688185; HKSE:6185), Venus MedTech (HKSE:2500), dMed, Chain Medical Labs, Berry Oncology, Belief BioMed, ZhenGe, Valgen among others.

Nisa has been recognized by the Forbes Global 100 VC Midas List in 2019-2022 and named Top Women VCs by Forbes China in 2018-2022, most recently #1.

Nisa earned her MBA from Stanford Graduate School of Business and a BS from Cornell University. She is visiting lecturer at Harvard Law School, member of Stanford Graduate School of Business Advisory Council and serves as board member of the Hong Kong Exchanges and Clearing Limited and Hong Kong Palace Museum.